ASCRS Ch36 - Colorectal Cancer: Minimally Invasive Surgery

Chapter 36, "Colorectal Cancer: Minimally Invasive Surgery," ASCRS Textbook of Colon and Rectal Surgery, 4th edition. Author: Antonino Spinelli. Book pp. 619–642 (title page through References).

Textbook reference chapter (not primary literature), focused specifically on minimally invasive techniques for rectal cancer surgery (the author notes colectomy MIS is well-accepted and less controversial; the chapter's remainder focuses on the more controversial application to proctectomy). Substantially corroborates and technically extends the wiki's existing Total Mesorectal Excision (TME) & Sphincter-Sparing Resection page (built from ASCRS Ch29 - Proctectomy for Rectal Cancer) and Abdominoperineal Resection (APR) page.

History and controversy

First laparoscopic-assisted colectomies for cancer: 1991 (Schlender, Fowler & White, Jacobs et al.). Early port-site tumor recurrence concerns (a 1994 report cited 21% port-site recurrence rates, prompting several surgical societies to advise against laparoscopy for curable cancer) were later resolved — subsequent series found port-site recurrence rates ~1%, similar to open-surgery wound implant rates; an ASCRS registry reported a 0.4% incisional recurrence rate after laparoscopic colon cancer surgery. RCTs in the late 1990s/early 2000s established laparoscopic colectomy's oncologic noninferiority for curable intraperitoneal colon cancer, with faster recovery (~1 day shorter stay) and better short-term function/cosmesis, at the cost of longer operative time.

Laparoscopic proctectomy is more controversial than colectomy. The CLASICC trial found a 12% rate of involved circumferential radial margins (CRM) after laparoscopic restorative proctectomy vs. 6% in the open arm, and a 34% conversion rate — concluding suboptimal short-term outcomes did not yet justify routine laparoscopic use, though 5-year follow-up showed no OS/DFS differences. The COREAN trial showed short-term benefits (decreased blood loss, postoperative pain, length of stay) and comparable 3-year DFS for laparoscopic vs. open proctectomy after neoadjuvant chemoradiation in non-metastatic mid-low rectal cancer. Two large RCTs, ACOSOG Z6051 (US) and ALaCaRT (Australia/NZ), failed to demonstrate laparoscopic noninferiority using a composite successful- resection measure (negative radial margin, negative distal margin, complete/nearly-complete mesorectal grade); no differences in hospital stay; shorter incision length in the laparoscopic group. The ACOSOG trial's 3-year DFS was equivalent between laparoscopic and open groups despite the mesorectal-quality concerns. This corroborates the wiki's existing (Ch29-sourced) ACOSOG-Z6051/ALaCaRT summary with matching trial detail and CRM figures, and adds the CLASICC and COREAN trials, which the existing wiki page did not previously name.

Laparoscopic proctectomy technique

Detailed step-by-step technique: patient positioning (lithotomy or supine split-leg, head/chest/arms tucked for Trendelenburg tilt), port placement (umbilical camera port, RLQ 10-12mm stapling port, three 5mm assistant ports), medial-to-lateral IMA/IMV dissection (with real-time indocyanine green (ICG) angiography under near-infrared light usable for real-time ureteral visualization via mono-J ureteral stents — a distinct application from ICG's more common anastomotic-perfusion use), splenic flexure/left colon mobilization, and TME-principled mesorectal mobilization (hypogastric nerve identification, Denonvilliers' fascia-based anterior dissection plane depending on tumor location, distal transection with ≥1cm margin).

Three critical points for colorectal vascular supply (a named anatomic-risk figure, genuinely new content for the wiki): (1) the splenic flexure (Griffith's point) is vulnerable to ischemia because the marginal artery of Drummond is occasionally tenuous here and absent in up to 5% of patients — a 1.2–2.8cm² area may be devoid of vasa recta; (2) the right colon may be vulnerable in systemic low-flow states, as the marginal artery of Drummond is poorly developed here in 50% of the population; (3) the rectosigmoid junction (Sudek's point) is also vulnerable, being distal to the last collateral connection with proximal arteries.

Distal rectal transection technical limitations: the fulcrum effect of operating a stapler through an iliac-fossa port; limited stapler angulation (a virtual simulation study showed staplers would need to go through the iliac bone to achieve a 90° transection angle at the levator ani level); multiple staple-firing requirement (single-firing perpendicular transection is ideal but often not achievable, possibly increasing anastomotic leak risk); intersecting lateral staple lines ("dog ears") after double-stapled anastomosis are considered weak structural spots prone to leak. Techniques to reduce dog ears: the "tennis racket" technique (anvil spike brought through the rectal stump laterally rather than centrally, eliminating one intersecting staple line) and the "reverse smile" technique (spike brought through just posterior to the linear staple line, then the stapler shaft retracted and angled anteriorly, pulling the staple line edges toward the midline posterior to the spike) — the latter can transform a double-stapled into an essentially single-stapled anastomosis. Alternative: a hand-assisted device inserted at this point in the case ameliorates the fulcrum effect, stabilizes pneumoperitoneum via the hand-port seal, and allows tumor palpation for a safe distal margin, at increased cost.

ICG fluorescence angiography (ICG-FA) is used to assess proximal colon conduit perfusion before transection, and again after anastomosis for a final perfusion check — though the chapter notes there are no definitive data yet proving ICG-FA outperforms other perfusion-assessment methods; results of the ongoing IntAct RCT should clarify this. This corroborates, and adds a specific ongoing-trial name to, the wiki's existing PILLAR-II-based ICG-FA content on Anastomotic Construction.

Air leak testing: standard (via proctoscopy) or reverse (via peritoneal insufflation) technique performed after anastomosis completion.

Laparoscopic abdominoperineal resection (APR)

APR is still required in ~18% of rectal cancer patients despite sphincter-preservation advances. Limited RCT data specific to APR (most published RCTs comparing laparoscopic/open rectal resection included APR cases without a dedicated subset analysis). Ng et al. conducted a prospective RCT specifically in low rectal cancer comparing open (n=48) vs. laparoscopic (n=51) APR: earlier return of bowel function (3.1 vs. 4.1 days, p<0.001) and improved time to independent ambulation (4.4 vs. 5.9 days, p=0.005) with laparoscopic APR, but higher cost ($9588 vs. $7517, p<0.001) and longer operative time (213 vs. 163 min, p<0.001); 5-year survival was equivalent (75% vs. 76%, p=0.20), consistent with CLASICC's findings. CRM reporting is inconsistent across the laparoscopic-APR literature — among 19 studies published since 1994 reporting oncologic outcomes, only 6 reported CRM involvement rates (ranging 2–21%); two studies (including the Dutch TME trial) found an association between higher tumor stage and CRM involvement, with the Dutch trial's APR subset showing 30% CRM positivity — raising selection-bias concerns for non-randomized laparoscopic-APR comparisons (patients with more advanced tumors more likely to undergo open surgery). Overall existing data suggest laparoscopic APR, performed by skilled surgeons, is associated with reasonable oncologic outcomes and possibly faster recovery. Robotic APR is feasible/safe in select patients per the few published studies, with functional outcomes comparable to laparoscopic APR; one study reported lower conversion rates but higher total hospital charges with robotic vs. laparoscopic APR, and faster bowel recovery plus a trend toward reduced CRM+ vs. open APR.

Laparoscopic perineal approach: an alternative retrograde perineal technique (dissection plane created in the pelvis before entering the peritoneal cavity) using a single-port laparoscopic or TEM device positioned within the ischiorectal/extrasphincteric dissection space — still in its infancy, with little feasibility/safety/outcomes data yet published.

Robotic rectal cancer surgery

First robotic proctectomy for cancer described in 2006. Theoretical advantages: magnified 3D view, improved ergonomics/dexterity (7 degrees of freedom), stable camera holding, tremor filtering, motion scaling, shorter learning curve. Disadvantages: lack of haptic feedback, longer operative time, and cost. The ROLARR RCT (using conversion-to-open as its primary outcome) failed to demonstrate that robotic surgery reduces conversion rate vs. laparoscopy, and found no difference in short- or long-term outcomes between the two approaches; robotic surgery was on average £980 more expensive than laparoscopic, even excluding acquisition/maintenance costs. Other RCTs found similar short-term, long-term, and functional outcomes between laparoscopic and robotic approaches. Docking is the most time-consuming aspect of robotic surgery, especially with multiple dockings required, though recent meta-analyses show similar operating times for robotic and laparoscopic proctectomy as surgical teams gain experience. Robotic proctectomy can be fully robotic or a hybrid laparoscopic/robotic technique (splenic flexure mobilization and vessel ligation performed laparoscopically, with the robot docked only for rectal mobilization) — no comparative studies show one superior; the hybrid approach allows the robot's benefit where it matters most (the narrow pelvis) while avoiding time-consuming re-docking for splenic flexure work. Detailed port-placement/instrument-arm setup differs between the da Vinci Xi and Si platforms (Figs. 36.20–36.23 in the source — trocar positions, camera/assistant port arrangement).

Robotic APR/ELAPE: applicable using the same principles; wide levator resection to avoid "coning in" and creating a waist in the specimen, extending distally into the ischiorectal fat before the perineal phase.

Transanal total mesorectal excision (TaTME)

Proposed in 2010 to overcome technical challenges of abdominal (open/laparoscopic/robotic) approaches in difficult cases (obese, male, mid-low rectal tumors, narrow/radiated pelvis, bulky mesorectum). Built on transabdominal-transanal proctosigmoidectomy (TATA), TEM, TAMIS, NOSE, and NOTES techniques. Claimed advantages: longer distal resection margin (direct visual control of transection), decreased positive-CRM rate, improved TME quality. Controversial given lack of RCTs vs. open/laparoscopic/ robotic TME and safety concerns — urethral injury, CO2 embolism, and (very rarely reported in other approaches) multifocal local recurrence potentially related to pneumoinsufflation and cancer cell spread. A recent six-center study focused on local recurrence after TaTME found a 2-year LR rate of 3% with no multifocal recurrence pattern, suggesting good locoregional control with standardized technique. The ongoing COLOR III multicenter RCT should better define TaTME's relative short- and long-term oncologic outcomes vs. laparoscopic TME. This corroborates the wiki's existing Total Mesorectal Excision (TME) & Sphincter-Sparing Resection taTME section (which already covers the two-team technique and the International taTME Registry's serious-complication concerns), adding the CO2 embolism/urethral-injury safety detail, the multifocal-recurrence controversy, the 3% 2-year-LR reassurance data, and the COLOR III trial name — all genuinely new to the wiki.

Detailed technique (abdominal + transanal): standard abdominal steps (left colon/splenic flexure mobilization, IMA/IMV division, proximal mesorectal mobilization) can be performed before, after, or synchronous with transanal mobilization. Transanal setup: lithotomy/Trendelenburg positioning, pudendal block, self-retaining retractor to visualize the dentate line, transanal platform placement (author's preference: flexible U-shaped platform), purse-string suture placement (distance from anal verge/tumor determined by tumor-to-anorectal-junction distance: 3cm if tumor >4cm from ARJ, 1cm distal to tumor if 2–4cm from ARJ, dissection started without the platform if <2cm from ARJ). A rectal washout is typically performed after the purse-string is tied (rationale: reduce fecal contamination and possibly tumor cell implantation, though no data confirm this). 360° full-thickness rectal wall incision, then circumferential mesorectal dissection (posterior plane safest to start — avascular presacral space; anterior plane in the rectovaginal septum in women or rectoprostatic plane in men, taking care to avoid urethral/prostate injury; lateral dissection near the neurovascular bundle at 2 and 10 o'clock is a described danger zone). Specimen extracted transanally (if mesorectal bulk is limited) or transabdominally. Single-stapled colorectal or coloanal anastomosis performed after proximal purse-string placement and spike/anvil connection; air leak test and ICG-FA perfusion check performed; proximal fecal diversion (loop ileostomy/colostomy) typically follows.

Hand-assisted laparoscopic surgery (HALS)

Developed in the late 1990s to overcome laparoscopic limitations while retaining most laparoscopic benefits. Uses a hand-assist device (stable platform, circumferential wound retraction, self-sealing membrane for hand exchange/trocar placement while maintaining pneumoperitoneum) through a 4–8cm incision (sized to the surgeon's glove size) that is used from the start of the case for both mesenteric mobilization/anastomosis and (if favorable body habitus) direct hand-assisted mesorectal mobilization ("hybrid" approach). HALAR (hand-assisted laparoscopic anterior resection) findings, summarizing 11 comparative studies: retains many pure-laparoscopic benefits; comparable complication rate and length of stay vs. straight laparoscopic approach; comparable oncologic outcomes vs. laparoscopic or open; shorter operative time and lower conversion rate than straight laparoscopy; slightly longer incision (unclear clinical significance); increased inflammatory-marker levels (unclear clinical significance) vs. straight laparoscopic. HALS allows the recommendation to avoid straight laparoscopic proctectomy for rectal cancer (per the CLASICC/ACOSOG/ALaCaRT concerns above) to be honored while still gaining most laparoscopic benefits, particularly in patients with unfavorable body habitus.

Open items / gaps

• CLASICC, COREAN, ACOSOG Z6051, ALaCaRT, ROLARR, Ng et al.'s laparoscopic-APR RCT, and COLOR III are not independently ingested as primary literature — all captured only via this textbook chapter's narrative summary. ACOSOG Z6051/ALaCaRT were already flagged as non-primary-source on the existing wiki page; this chapter does not resolve that gap, only corroborates with matching detail.
• The IntAct RCT (ICG-FA vs. standard perfusion assessment) has not yet reported results per this chapter — worth revisiting once published.
• Robotic APR/ELAPE evidence is described as limited to a "few published studies" without individual study detail beyond the one comparative-cost finding noted above.